<!doctype html> <html> <head><style>
             table { border-collapse: collapse; }
             th, td {
               word-wrap: break-word;
               max-width: 100%;
               font-family: "Trebuchet MS", Arial, Helvetica, sans-serif;
               border-bottom: 1px solid #ddd;
               padding: 5px;
               text-align: left;
             }
            tr:hover {background: #f4f4f4;}
            tr:hover .highlighted {background: repeating-linear-gradient(
                    45deg,
                    #ffff99,
                    #ffff99 10px,
                    #f4f4f4 10px,
                    #f4f4f4 20px
                  );}
           .highlighted { background-color: #ffff99; }
          </style></head><body><h2>Pharmacology of bicalutamide</h2><br> <b>Section Title</b>: Pharmacokinetics <br><b>Table Section Text</b>: The pharmacokinetics of bicalutamide are unaffected by food, age, body weight, renal impairment, and mild-to-moderate hepatic impairment. However, it has been observed that steady-state concentrations of bicalutamide are higher in Japanese individuals than in Caucasians, indicating that ethnicity may be associated with differences in the pharmacokinetics of bicalutamide in some instances. <br> <table>
<tr> <th colspan=1 rowspan=1 >  </th><th colspan=1 rowspan=1 > 50 mg/day </th><th colspan=1 rowspan=1 > 150 mg/day </th></tr>
<tr> <td colspan=1 rowspan=1 > Cmax </td><td colspan=1 rowspan=1 > 0.77 μg/mL (1.8 μmol/L) </td><td colspan=1 rowspan=1 > 1.4 μg/mL (3.3 μmol/L) </td></tr>
<tr> <td colspan=1 rowspan=1 > tmax </td><td colspan=1 rowspan=1 > 31 hours </td><td colspan=1 rowspan=1 > 39 hours </td></tr>
<tr> <td class="highlighted"  colspan=1 rowspan=1 > Css </td><td class="highlighted"  colspan=1 rowspan=1 > 8.85 μg/mL (20.6 μmol/L) </td><td class="highlighted"  colspan=1 rowspan=1 > 21.6–28.5 μg/mL (50.2–66.3 μmol/L) </td></tr>
<tr> <td colspan=1 rowspan=1 > tss </td><td colspan=1 rowspan=1 > 4–12 weeks </td><td colspan=1 rowspan=1 > 4–12 weeks </td></tr>
<tr> <td colspan=3 rowspan=1 > Notes: All values are for (R)-bicalutamide. Sources: </td></tr>
</table> <br> <h3>Sentence(s)</h3>1. At steady-state concentrations (Cₛₛ) of (R)-bicalutamide with 50 mg/day and 150 mg/day bicalutamide are 8.85 μg/mL (20.6 μmol/L) and 21.6 μg/mL (50.2 μmol/L). <br> <br><br><b>Categories:</b><br><b>Numerical:</b> Uses math skills for writing the sentence. Uses math operations (addition, subtraction, average, etc.), counting numbers, frequency of items, etc.<br> <b>Commonsense:</b> Uses commonsene knowledge about situations humans encounter in everyday life – physical objects, word meanings, social or physical domains, peoples' intentions, etc.<br> <b>Temporal:</b> When concepts related to time and temporal aspects are required for writing the sentence. Duration, ordering, typical time of events, time differences between events.<br> <b>Table:</b> Writing the sentence requires knowledge from the table except: the highlighted cells, row and column headers, table titles, section titles, section texts.<br> <b>Out of Table:</b> Writing the sentence requires external knowledge that is not present in the table nor common sense. Knowledge about some specific domain comes under this category. </body></html>
